Fludiazepam

DB01567IllicitInvestigationalSmall molecule

Fludiazepam is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a scheduled drug in the U.S., but is approved...

Chemical structure of Fludiazepam
Mechanism
Curator reviewed
Primary indication
Used for the short-term treatment of anxiety disorders.Curator reviewed
Formula / weight
C16H12ClFN2O · 302.731 g/mol (avg)
Code names
ID 540 · Ro 5-3438

Resolves to

Compound
UNII7F64A2K16ZCAS3900-31-0ChEMBLCHEMBL13291ChEBI31618PubChem3369KEGGD01354
Clinical / RWD
ATCN05BA17PharmGKBPA164745609
Structure
InChIKeyROYOYTLGDLIGBX-UHFFFAOYSA-NSMILESCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Targets
P14867GABRA1P47869GABRA2P34903GABRA3P31644GABRA5Q8N1C3GABRG1P18507GABRG2Q99928GABRG3P18505GABRB1+9 more

What you can answer from here — as of September 23, 2026

17Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
720Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
19+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fludiazepam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In